STANDARD BIOTOOLS INC. Quarterly Amortization of Intangible Assets in USD from Q1 2013 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.
Summary
Standard Biotools Inc. quarterly/annual Amortization of Intangible Assets history and growth rate from Q1 2013 to Q1 2024.
  • Standard Biotools Inc. Amortization of Intangible Assets for the quarter ending March 31, 2024 was $2.11M, a 24.8% decline year-over-year.
  • Standard Biotools Inc. Amortization of Intangible Assets for the twelve months ending March 31, 2024 was $10.5M, a 6.43% decline year-over-year.
  • Standard Biotools Inc. annual Amortization of Intangible Assets for 2023 was $11.2M, a 2.85% decline from 2022.
  • Standard Biotools Inc. annual Amortization of Intangible Assets for 2022 was $11.5M, a 3.27% decline from 2021.
  • Standard Biotools Inc. annual Amortization of Intangible Assets for 2021 was $11.9M, a 0.07% increase from 2020.
Amortization of Intangible Assets, Trailing 12 Months (USD)
Amortization of Intangible Assets, Quarterly (USD)
Amortization of Intangible Assets, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $10.5M $2.11M -$694K -24.8% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $11.2M $2.4M +$72K +3.09% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-01
Q3 2023 $11.1M $3M +$100K +3.45% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-07
Q2 2023 $11M $3M -$200K -6.25% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-08
Q1 2023 $11.2M $2.8M -$300K -9.68% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 $11.5M $2.33M -$307K -11.7% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-01
Q3 2022 $11.8M $2.9M -$200K -6.45% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 $12M $3.2M $0 0% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 $12M $3.1M +$117K +3.92% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 $11.9M $2.64M Oct 1, 2021 Dec 31, 2021 10-K 2023-03-14
Q3 2021 $3.1M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 $3.2M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 $2.98M +$15K +0.51% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
Q1 2020 $2.97M +$168K +6% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-07
Q1 2019 $2.8M $0 0% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q3 2018 $3.1M $0 0% Jul 1, 2018 Sep 30, 2018 10-Q 2018-11-06
Q1 2018 $2.8M $0 0% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-07
Q3 2017 $3.1M Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-06
Q1 2017 $2.8M $0 0% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-08
Q1 2016 $2.8M $0 0% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-09
Q1 2015 $2.8M +$1.4M +100% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-09
Q1 2014 $1.4M +$1.4M Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-11
Q1 2013 $0 Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.